Matrix-forming composition containing pectin
Abstract
One aspect of the present invention relates to a liquid edible composition with a pH of more than 6, a viscosity below 50 mPas at a shear rate of 100 s −1 and 20° C., and a viscosity of at least 125% of the aforementioned viscosity at a pH below 5 and a temperature of 37° C., the composition comprising at least 0.05 wt. % of pectin having a degree of methoxylation between 2 and 50 and/or of alginate; and at least 5 mg calcium per 100 ml; and between 1 and 25 g protein per 100 ml. Another aspect of the invention relates to a method for the treatment or prevention of overweight or obesity in mammals, said method comprising the enteral administration to a mammal of an effective amount of the aforementioned composition.
Claims
exact text as granted — not AI-modified1 . A liquid edible composition with a pH of more than 6, a viscosity below 50 mPas at a shear rate of 100 s −1 and 20° C., and a viscosity of at least 125% of the aforementioned viscosity at a pH below 5 and a temperature of 37° C., the composition comprising:
a. at least 0.05 wt. % of pectin having a degree of methoxylation between 2 and 50 and/or of alginate;
b. at least 5 mg calcium per 100 ml; and
c. between 1 and 25 grams protein per 100 ml;
2 . A composition according to claim 1 , wherein the composition has a viscosity of at least 250 mPas at pH 3 and a temperature of 37° C.
3 . A composition according to claim 1 , comprising between 0.1 g and 10 gram soluble fiber per 100 ml.
4 . A composition according to claim 3 , wherein said fiber is selected from the group consisting of high methoxylated pectin, chitosan, β-glucan, soluble fibre from psyllium husk, xanthan gum, guar gum, locust bean gum, gum arabic, soy fibre and mixtures thereof
5 . A composition according to claim 1 , comprising between 0.2 and 10 wt. % lipids.
6 . A composition according to claim 1 , comprising between 0.5 and 20 g digestible maltodextrins per 100 ml.
7 . A composition according to claim 1 , comprising at least 3 bioactive agents selected from the group consisting of Vitamin A, Vitamin E, Vitamin K, Vitamin C, Vitamin D, Thiamin, Riboflavin, Niacin, Vitamin B6, Folic acid, Vitamin B12, Biotin and Pantothenic acid.
8 . A composition according to claim 7 , wherein at least 3 of the bioactive agents are present in an amount ranging from 5% of the recommended daily intake to 250% of the recommended daily intake.
9 . A composition according to claim 1 , comprising at least 3 minerals selected from the group consisting of iron, zinc, copper, chromium, iodine, selenium, magnesium, manganese, molybdenum, choline, potassium, phosphate and chloride.
10 . A composition according to claim 9 , wherein at least 3 of the minerals are present in an amount ranging from 5% of the recommended daily intake to 250% of the recommended daily intake.
11 . A composition according to claim 1 , comprising between 0.4 and 5 wt. % pectin having a degree of methoxylation between 5% and 45%.
12 . A composition according to claim 1 , wherein the calcium is provided by a calcium salt which has a solubility below 0.10 grams per 100 ml (demineralized) water at pH 7 and 20° C.
13 . A composition according to claim 1 , comprising between 0.1 and 10 grams calcium per 100 ml.
14 . A composition according to claim 1 , wherein the composition is sterilized or pasteurized and/or contains added flavoring.
15 . A composition according to claim 1 , wherein the calcium salt is selected from the group consisting of calcium phosphate, calcium carbonate, calcium sulfate, calcium oxide, calcium citrate, a calcium salt coated with a substance which has limited solubility in water at pH 7 and which is soluble at a pH below 5 and mixtures thereof.
16 . A composition according to claim 1 , comprising between 50 and 98 wt. % water.
17 . A packaged beverage product comprising between 50 and 1000 ml of a composition according to claim 1 .
18 . A method for the treatment or prevention of overweight or obesity in mammals, said method comprising the enteral administration to a mammal of an effective amount of a composition according to claim 1.Join the waitlist — get patent alerts
Track US2003198726A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.